UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 44

Sortiert nach

Glio-vascular changes during ageing in wild-type and Alzheimer's disease-like APP/PS1 mice

Brain research, 2015-09, Vol.1620, p.153-168

2015

Volltextzugriff (PDF)

Neuroprotective natural antibodies to assemblies of amyloidogenic peptides decrease with normal aging and advancing Alzheimer's disease

Proceedings of the National Academy of Sciences - PNAS, 2009-07, Vol.106 (29), p.12145-12150

2009

Volltextzugriff (PDF)

Minocycline affects microglia activation, Aβ deposition, and behavior in APP-tg mice

Glia, 2006-05, Vol.53 (7), p.776-782

2006

Volltextzugriff (PDF)

Amyloid β protein immunotherapy neutralizes Aβ oligomers that disrupt synaptic plasticity in vivo

Nature medicine, 2005-05, Vol.11 (5), p.556-561

2005

Volltextzugriff (PDF)

APP Processing Is Regulated by Cytoplasmic Phosphorylation

The Journal of cell biology, 2003-10, Vol.163 (1), p.83-95

2003

Volltextzugriff (PDF)

A Seed for Alzheimer Amyloid in the Brain

The Journal of neuroscience, 2004-05, Vol.24 (20), p.4894-4902

2004

Volltextzugriff (PDF)

Short Amyloid-β (Aβ) Immunogens Reduce Cerebral Aβ Load and Learning Deficits in an Alzheimer's Disease Mouse Model in the Absence of an Aβ-Specific Cellular Immune Response

The Journal of neuroscience, 2006-05, Vol.26 (18), p.4717-4728

2006

Volltextzugriff (PDF)

Huperzine A regulates amyloid precursor protein processing via protein kinase C and mitogen-activated protein kinase pathways in neuroblastoma SK-N-SH cells over-expressing wild type human amyloid precursor protein 695

Neuroscience, 2007-12, Vol.150 (2), p.386-395

2007

Volltextzugriff (PDF)

A beneficial role for IL-1 beta in Alzheimer disease?

The Journal of clinical investigation, 2007-06, Vol.117 (6), p.1483-1485

Lemere, Cynthia A

2007

Volltextzugriff (PDF)

Alzheimer's Disease Aβ Vaccine Reduces Central Nervous System Aβ Levels in a Non-Human Primate, the Caribbean Vervet

The American journal of pathology, 2004-07, Vol.165 (1), p.283-297

2004

Volltextzugriff (PDF)

Reduced beta-amyloid production and increased inflammatory responses in presenilin conditional knock-out mice

The Journal of biological chemistry, 2004-11, Vol.279 (45), p.46907-46914

2004

Volltextzugriff (PDF)

Inflammatory Responses to Amyloidosis in a Transgenic Mouse Model of Alzheimer’s Disease

The American journal of pathology, 2001-04, Vol.158 (4), p.1345-1354

2001

Volltextzugriff (PDF)

Evidence for peripheral clearance of cerebral Aβ protein following chronic, active Aβ immunization in PSAPP mice

Neurobiology of disease, 2003-10, Vol.14 (1), p.10-18

2003

Volltextzugriff (PDF)

Sequence of Deposition of Heterogeneous Amyloid β-Peptides and APO E in Down Syndrome: Implications for Initial Events in Amyloid Plaque Formation

Neurobiology of disease, 1996-02, Vol.3 (1), p.16-32

1996

Volltextzugriff (PDF)

The Swedish mutation causes early-onset Alzheimer's disease by β-secretase cleavage within the secretory pathway

Nature medicine, 1995-12, Vol.1 (12), p.1291-1296

1995

Volltextzugriff (PDF)

Temporal Accrual of Complement Proteins in Amyloid Plaques in Down's Syndrome with Alzheimer's Disease

The American journal of pathology, 2000-02, Vol.156 (2), p.489-499

2000

Volltextzugriff (PDF)

Modulation of the humoral and cellular immune response in Aβ immunotherapy by the adjuvants monophosphoryl lipid A (MPL), cholera toxin B subunit (CTB) and E. coli enterotoxin LT(R192G)

Vaccine, 2005-10, Vol.23 (44), p.5149-5159

2005

Volltextzugriff (PDF)

The E280A presenilin 1 Alzheimer mutation produces increased A beta 42 deposition and severe cerebellar pathology

Nature medicine, 1996-10, Vol.2 (10), p.1146-1150

1996

Volltextzugriff (PDF)

Preferential labeling of Alzheimer neurofibrillary tangles with antisera for tau protein kinase (TPK) I/glycogen synthase kinase-3 beta and cyclin-dependent kinase 5, a component of TPK II

Acta neuropathologica, 1996-09, Vol.92 (3), p.232-241

1996

Volltextzugriff (PDF)

Amyloid-beta immunotherapy for the prevention and treatment of Alzheimer disease: lessons from mice, monkeys, and humans

Rejuvenation research, 2006-03, Vol.9 (1), p.77

2006

Volltextzugriff (PDF)

Nasal Aβ Treatment Induces Anti-Aβ Antibody Production and Decreases Cerebral Amyloid Burden in PD-APP Mice

Annals of the New York Academy of Sciences, 2000-01, Vol.920 (1), p.328-331

2000

Volltextzugriff (PDF)

Synthesis and Amyloid Binding Properties of Rhenium Complexes: Preliminary Progress Toward a Reagent for SPECT Imaging of Alzheimer's Disease Brain

Journal of medicinal chemistry, 1999-07, Vol.42 (15), p.2805-2815

1999

Volltextzugriff (PDF)

Nasal vaccination with beta-amyloid peptide for the treatment of Alzheimer's disease

DNA and cell biology, 2001-11, Vol.20 (11), p.705

2001

Volltextzugriff (PDF)

Intranasal immunotherapy for the treatment of Alzheimer's disease: Escherichia coli LT and LT(R192G) as mucosal adjuvants

Neurobiology of aging, 2002-11, Vol.23 (6), p.991-1000

2002

Volltextzugriff (PDF)

Localization of flotillins in human brain and their accumulation with the progression of Alzheimer's disease pathology

Neuroscience letters, 2000-08, Vol.290 (2), p.93-96

2000

Volltextzugriff (PDF)

1 – 25 von 44

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(42)
Mit Volltextzugriff
(41)

Publikationsform

Artikel
(44)

Sprache

Englisch
(44)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Glio-vascular changes during ageing in wild-type and Alzheimer's disease-like APP/PS1 mice

Neuroprotective natural antibodies to assemblies of amyloidogenic peptides decrease with normal aging and advancing Alzheimer's disease

Minocycline affects microglia activation, Aβ deposition, and behavior in APP-tg mice

Amyloid β protein immunotherapy neutralizes Aβ oligomers that disrupt synaptic plasticity in vivo

APP Processing Is Regulated by Cytoplasmic Phosphorylation

A Seed for Alzheimer Amyloid in the Brain

Short Amyloid-β (Aβ) Immunogens Reduce Cerebral Aβ Load and Learning Deficits in an Alzheimer's Disease Mouse Model in the Absence of an Aβ-Specific Cellular Immune Response

Huperzine A regulates amyloid precursor protein processing via protein kinase C and mitogen-activated protein kinase pathways in neuroblastoma SK-N-SH cells over-expressing wild type human amyloid precursor protein 695

A beneficial role for IL-1 beta in Alzheimer disease?

Alzheimer's Disease Aβ Vaccine Reduces Central Nervous System Aβ Levels in a Non-Human Primate, the Caribbean Vervet

Reduced beta-amyloid production and increased inflammatory responses in presenilin conditional knock-out mice

Inflammatory Responses to Amyloidosis in a Transgenic Mouse Model of Alzheimer’s Disease

Evidence for peripheral clearance of cerebral Aβ protein following chronic, active Aβ immunization in PSAPP mice

Sequence of Deposition of Heterogeneous Amyloid β-Peptides and APO E in Down Syndrome: Implications for Initial Events in Amyloid Plaque Formation

The Swedish mutation causes early-onset Alzheimer's disease by β-secretase cleavage within the secretory pathway

Temporal Accrual of Complement Proteins in Amyloid Plaques in Down's Syndrome with Alzheimer's Disease

Modulation of the humoral and cellular immune response in Aβ immunotherapy by the adjuvants monophosphoryl lipid A (MPL), cholera toxin B subunit (CTB) and E. coli enterotoxin LT(R192G)

The E280A presenilin 1 Alzheimer mutation produces increased A beta 42 deposition and severe cerebellar pathology

Preferential labeling of Alzheimer neurofibrillary tangles with antisera for tau protein kinase (TPK) I/glycogen synthase kinase-3 beta and cyclin-dependent kinase 5, a component of TPK II

Amyloid-beta immunotherapy for the prevention and treatment of Alzheimer disease: lessons from mice, monkeys, and humans

Nasal Aβ Treatment Induces Anti-Aβ Antibody Production and Decreases Cerebral Amyloid Burden in PD-APP Mice

Synthesis and Amyloid Binding Properties of Rhenium Complexes: Preliminary Progress Toward a Reagent for SPECT Imaging of Alzheimer's Disease Brain

Nasal vaccination with beta-amyloid peptide for the treatment of Alzheimer's disease

Intranasal immunotherapy for the treatment of Alzheimer's disease: Escherichia coli LT and LT(R192G) as mucosal adjuvants

Localization of flotillins in human brain and their accumulation with the progression of Alzheimer's disease pathology

Suchergebnisse filtern